CXCL13 and neoplasm: CAF and TGFβ inhibition also reduces the expression of Th2 cytokine and chemokine CXCL13, decreases myeloid-derived suppressor cells, Tregs, and M2 macrophages in the tumor area, and decreases tumor growth and metastasis to the lungs [538].